Citius Pharmaceuticals Files 8-K

Ticker: CTXR · Form: 8-K · Filed: Jul 8, 2025 · CIK: 1506251

Sentiment: neutral

Topics: 8-K, filing, pharmaceuticals

Related Tickers: CTRS

TL;DR

CTRS filed an 8-K on July 8th, reporting on events and financials from July 7th.

AI Summary

Citius Pharmaceuticals, Inc. filed an 8-K on July 8, 2025, reporting on other events and financial statements/exhibits. The filing date is July 8, 2025, with the earliest event reported on July 7, 2025. The company, incorporated in Nevada, is in the Pharmaceutical Preparations industry.

Why It Matters

This 8-K filing indicates that Citius Pharmaceuticals, Inc. is providing updates or submitting required documentation to the SEC, which could contain material information for investors.

Risk Assessment

Risk Level: low — This filing is a routine 8-K for other events and exhibits, not indicating any immediate significant operational or financial distress.

Key Players & Entities

FAQ

What specific 'Other Events' are being reported in this 8-K filing?

The provided text does not detail the specific 'Other Events' covered in the 8-K, only that this item information is included.

What is the significance of the 'Financial Statements and Exhibits' being filed?

The filing of 'Financial Statements and Exhibits' suggests the company is providing updated financial information or supplementary documents as required by the SEC.

When was Citius Pharmaceuticals, Inc. incorporated, and in which state?

Citius Pharmaceuticals, Inc. was incorporated in Nevada.

What is the primary business of Citius Pharmaceuticals, Inc. according to its SIC code?

According to its Standard Industrial Classification (SIC) code 2834, Citius Pharmaceuticals, Inc. is in the business of Pharmaceutical Preparations.

What is the principal executive office address for Citius Pharmaceuticals, Inc.?

The principal executive offices are located at 11 Commerce Drive, 1st Floor, Cranford, NJ 07016.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on July 8, 2025 regarding Citius Pharmaceuticals, Inc. (CTXR).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing